29.49
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Momenta Pharmaceuticals Inc | MNTA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 29.49 | 0.00 | 0.00 | 0.00 | 29.49 | 05:31:08 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 29.80 | 39.40 | 9.60 | 24.37% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 29.49 | USD |
Momenta Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.47B | 117.64M | 70.14M | $ 23.87M | $ - | -2.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Momenta Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNTA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.00 | 31.98 | 28.45 | 29.59 | 1,216,970 | -0.51 | -1.7% |
| 1 Month | 32.66 | 36.17 | 28.45 | 32.09 | 900,321 | -3.17 | -9.71% |
| 3 Months | 32.46 | 39.88 | 27.70 | 33.55 | 1,157,326 | -2.97 | -9.15% |
| 6 Months | 29.31 | 39.88 | 20.53 | 31.13 | 1,127,660 | 0.18 | 0.61% |
| 1 Year | 11.41 | 39.88 | 11.04 | 26.29 | 962,898 | 18.08 | 158.46% |
| 3 Years | 15.90 | 39.88 | 9.51 | 20.57 | 760,074 | 13.59 | 85.47% |
| 5 Years | 21.68 | 39.88 | 7.86 | 18.46 | 701,519 | 7.81 | 36.02% |
Momenta Pharmaceuticals Description
| Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic versions of MS drug Copaxone and anticoagulant Lovenox, and it receives royalties for these products through a partnership with Novartis. While a biosimilar version of Eylea is in the pipeline, Momenta terminated future development in generics/biosimilars in 2018. Several innovative drugs, including nipocalimab, M254, and M230, are in development to treat rare autoimmune diseases. |
